Cargando…
Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study
BACKGROUND: The aim of this analysis was to estimate biochemical parameters and the costs of treatment of secondary hyperparathyroidism (SHPT) in a subpopulation of the FARO-2 study. METHODS: The FARO-2 observational study aimed at evaluating the patterns of treatment for SHPT in naïve hemodialysis...
Autores principales: | Roggeri, Daniela Paola, Cozzolino, Mario, Mazzaferro, Sandro, Brancaccio, Diego, Paoletti, Ernesto, Roggeri, Alessandro, Costanzo, Anna Maria, di Luzio Paparatti, Umberto, Festa, Vincenzo, Messa, Piergiorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274130/ https://www.ncbi.nlm.nih.gov/pubmed/25565880 http://dx.doi.org/10.2147/IJNRD.S72011 |
Ejemplares similares
-
Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study
por: Messa, Piergiorgio, et al.
Publicado: (2015) -
Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs
por: Roggeri, Alessandro, et al.
Publicado: (2020) -
Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s
por: Ketteler, Markus, et al.
Publicado: (2022) -
Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy
por: Roggeri, Daniela Paola, et al.
Publicado: (2017) -
Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?
por: Frazão, João M, et al.
Publicado: (2012)